Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

Fintel reports that on November 18, 2024, BTIG initiated coverage of VYNE Therapeutics (NasdaqCM:VYNE) with a Buy ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

Plug Power downgraded at BTIG Research, citing need for more product sales to boost margins in the hydrogen market.

BTIG raised the firm’s price target on Syndax (SNDX) to $43 from $35 and keeps a Buy rating on the shares. The firm cites the company having ...

Donald Trump is returning to the White House without many of the guardrails of his first term. Many Never-Trump Republicans in Congress have converted or been defeated. Former economic adviser Gary ...

Shares of Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) have earned an average recommendation of “Buy” from the ...

Catalysts Co-hosts Brad Smith and Madison Mills dive into Nvidia earnings, Trump's ongoing Cabinet selections, and Musk's ...

Finally, BTIG Research raised their price objective on Independence Realty Trust from $18.00 to $21.00 and gave the company a ...

Plug Power (NASDAQ:PLUG) -1.1% in Thursday's trading as BTIG Research downgrades shares to Neutral from Buy, saying the company is "turning the corner but still [has] a lot of work to do." ...

Fintel reports that on November 14, 2024, BTIG downgraded their outlook for Plug Power (WBAG:PLUG) from Buy to Neutral. There are 668 funds or institutions reporting positions in Plug Power.